The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage ...

GSK Plc shares tumbled after its blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting ...

According to reports, the USFDA's Oncologic Advisory Committee voted that the risks from the drug, called Blenrep, outweighed ...

(Reuters) -European shares rose on Friday, on course for small weekly gains, as investors focussed on corporate earnings for ...

3M reports second-quarter earnings on Friday. Wall Street is looking for earnings per share of $2.01 from sales of $6.1 billion. In the wake of the offer being withdrawn Wednesday, analysts expect a ...

Reckitt Benckiser shares have lifted 2% or 110p to 5092p after the consumer goods giant secured a private equity buyer for its Air Wick and Cillit Bang operations. The FTSE 100-listed group said some ...

Allergy care market grows with rising allergy cases, biologic innovations, and demand for personalized, accessible treatment solutions wor ...

The yield on the US 30-year Treasury was unchanged at 4.99%. In London, GSK was the worst performer on the FTSE 100 index, down 6.2%. The US Food & Drug Administration Oncologic Drugs Advisory ...

On the downside, GSK tumbled after the US Food and Drug Administration recommended against approving its blood cancer drug ...